Capital International, Inc. Allogene Therapeutics, Inc. Transaction History

Capital International, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$25.79 - $39.02 $11.5 Million - $17.5 Million	-447,822 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$25.24 - $43.45 $2,624 - $4,518	-104 Reduced 0.02%	447,822 $11.3 Million
Q3 2020 Nov 13, 2020	SELL	$32.38 - $44.96 $9,390 - $13,038	-290 Reduced 0.06%	447,926 $16.9 Million
Q2 2020 Aug 14, 2020	BUY	$18.39 - $54.04 $8.24 Million - $24.2 Million	448,216 New	448,216 $19.2 Million

163

134M

59.4K

113K

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $280M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

Get notified when there are updates to the investment portfolio of Capital International, Inc., based on Form 13F filings with the SEC.

Stay updated on Capital International, Inc. with notifications on news.